Position in A
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$303,782
+$70,693 QoQ
Shares Held
2,287
+11.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#739
of 1,114 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026TRANSCEND CAPITAL ADVISORS, LLC holds $7,174,733 across 11 Diagnostics & Research names. A ranks #9 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
12,094 | $2,303,665 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,977 | $991,188 | |
| 3 | LH |
Labcorp Holdings Inc.
|
2,603 | $728,840 | |
| 4 | NTRA |
Natera, Inc.
|
2,405 | $652,837 | |
| 5 | ILMN |
Illumina, Inc.
|
3,604 | $633,691 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
886 | $469,216 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
2,241 | $433,006 | |
| 8 | WAT |
Waters Corp /De/
|
1,042 | $390,791 |
All Filings in A
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $303,782 | 2,287 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $233,089 | 2,045 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||